308 related articles for article (PubMed ID: 26611779)
1. Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.
Höner Zu Siederdissen C; Maasoumy B; Marra F; Deterding K; Port K; Manns MP; Cornberg M; Back D; Wedemeyer H
Clin Infect Dis; 2016 Mar; 62(5):561-7. PubMed ID: 26611779
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection.
Vermehren J; Peiffer KH; Welsch C; Grammatikos G; Welker MW; Weiler N; Zeuzem S; Welzel TM; Sarrazin C
Aliment Pharmacol Ther; 2016 Oct; 44(8):856-65. PubMed ID: 27549000
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
Martinello M; Dore GJ; Skurowski J; Bopage RI; Finlayson R; Baker D; Bloch M; Matthews GV
Open Forum Infect Dis; 2016 Apr; 3(2):ofw105. PubMed ID: 27419177
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs.
Roncero C; Villegas JL; Martínez-Rebollar M; Buti M
Expert Rev Clin Pharmacol; 2018 Oct; 11(10):999-1030. PubMed ID: 30199279
[TBL] [Abstract][Full Text] [Related]
5. High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
Macías J; Monge P; Mancebo M; Merchante N; Neukam K; Real LM; Pineda JA
HIV Med; 2017 Aug; 18(7):445-451. PubMed ID: 27882706
[TBL] [Abstract][Full Text] [Related]
6. The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection.
Garrison KL; German P; Mogalian E; Mathias A
Drug Metab Dispos; 2018 Aug; 46(8):1212-1225. PubMed ID: 29695614
[TBL] [Abstract][Full Text] [Related]
7. Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions.
Langness JA; Nguyen M; Wieland A; Everson GT; Kiser JJ
World J Gastroenterol; 2017 Mar; 23(9):1618-1626. PubMed ID: 28321163
[TBL] [Abstract][Full Text] [Related]
8. Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.
Hsu PY; Wei YJ; Lee JJ; Niu SW; Huang JC; Hsu CT; Jang TY; Yeh ML; Huang CI; Liang PC; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Hwang SJ; Chuang WL; Huang CF; Chiu YW; Yu ML
Clin Mol Hepatol; 2021 Jan; 27(1):186-196. PubMed ID: 33317251
[TBL] [Abstract][Full Text] [Related]
9. New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir.
McConachie SM; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2016; 9(2):287-302. PubMed ID: 26651915
[TBL] [Abstract][Full Text] [Related]
10. Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant Patients.
Burgess S; Partovi N; Yoshida EM; Erb SR; Azalgara VM; Hussaini T
Ann Pharmacother; 2015 Jun; 49(6):674-87. PubMed ID: 25770114
[TBL] [Abstract][Full Text] [Related]
11. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan.
Liu CH; Yu ML; Peng CY; Hsieh TY; Huang YH; Su WW; Cheng PN; Lin CL; Lo CC; Chen CY; Chen JJ; Ma Q; Brooks-Rooney C; Kao JH
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1290-1300. PubMed ID: 30362139
[TBL] [Abstract][Full Text] [Related]
13. No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk.
Mun EJ; Green P; Berry K; Ioannou GN
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):47-52. PubMed ID: 30142097
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatitis C virus infection in the Asia-Pacific region: an update.
Lim SG; Aghemo A; Chen PJ; Dan YY; Gane E; Gani R; Gish RG; Guan R; Jia JD; Lim K; Piratvisuth T; Shah S; Shiffman ML; Tacke F; Tan SS; Tanwandee T; Win KM; Yurdaydin C
Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):52-62. PubMed ID: 28404015
[TBL] [Abstract][Full Text] [Related]
15. Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.
Talavera Pons S; Boyer A; Lamblin G; Chennell P; Châtenet FT; Nicolas C; Sautou V; Abergel A
Br J Clin Pharmacol; 2017 Feb; 83(2):269-293. PubMed ID: 27530469
[TBL] [Abstract][Full Text] [Related]
16. Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals.
Cope R; Pickering A; Glowa T; Faulds S; Veldkamp P; Prasad R
AIDS Patient Care STDS; 2015 Jul; 29(7):379-83. PubMed ID: 26066094
[TBL] [Abstract][Full Text] [Related]
17. Drug interactions with new hepatitis C oral drugs.
Soriano V; Labarga P; Barreiro P; Fernandez-Montero JV; de Mendoza C; Esposito I; Benítez-Gutiérrez L; Peña JM
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):333-41. PubMed ID: 25553890
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study.
Hui VW; Au CL; Lam ASM; Yip TC; Tse YK; Lai JC; Chan HL; Wong VW; Wong GL
Hepatol Int; 2022 Dec; 16(6):1318-1329. PubMed ID: 36074319
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.
Smolders EJ; Smit C; T M M de Kanter C; Dofferiiof ASM; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM
J Acquir Immune Defic Syndr; 2017 Oct; 76(2):193-199. PubMed ID: 28902678
[TBL] [Abstract][Full Text] [Related]
20. Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection.
El-Sherif O; Khoo S; Solas C
Curr Opin HIV AIDS; 2015 Sep; 10(5):348-54. PubMed ID: 26248122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
